Global Nutrigenomics Testing Market

Nutrigenomics Testing Comprehensive Study by Application (Obesity, Diabetes, Cardiovascular Diseases, Cancer Research, Women's Health, Neurological, Others), Distribution Channel (Hospitals & Clinics, Online Platform) Players and Region - Global Market Outlook to 2030

Nutrigenomics Testing Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 15.48%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Nutrigenomics Testing
The increasing advancement in the field of proteomics, metabolomics, computational biology, genomics, and bioinformatics has exponentially driven the employment of the Nutrigenomics Testingglobally market. The scientific study of individualized genetics and nutrition is known as nutritional genomics or “nutrigenomics”. Nutrigenomic testing accurately identifies each patients’ genetic protein variations to identify sites of metabolic weakness. These key proteins are involved in enzyme conversion, nutritional delivery and signaling pathways in the cell.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR15.48%


A number of top manufacturers are shifting their focus on the development of tailor-made food to match a particular gene profile, such as strengthening of the weak immune system and decreased intake of cholesterol compounds. However, significant evidence is yet to be found to prove that it actually works. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Nutrigenomics Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Koninklijke DSM N.V. (Royal DSM) (Netherlands), BASF SE (Germany), Danone (France), GeneSmart (United States), Unilever (United Kingdom), Genova Diagnostics Inc. (United States), Nutrigenomix, Inc. (United States) and Metagenics, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are WellGen, Inc. (United States) and Cell Logic (United States).

Segmentation Overview
AMA Research has segmented the market of Global Nutrigenomics Testing market by , Application (Obesity, Diabetes, Cardiovascular Diseases, Cancer Research, Women's Health, Neurological and Others) and Region.



On the basis of geography, the market of Nutrigenomics Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Distribution Channel, the sub-segment i.e. Hospitals & Clinics will boost the Nutrigenomics Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Growing Trend of Personalized Diet among Athletes and The Rising Importance of Nutritious Food among the Preventive Measures for Obesity and Related Ailments

Market Growth Drivers:
The Growing Prevalence of Diabetes and Obesity and High Adoption due to Changing Lifestyle and Consumption of Junk Food

Challenges:
Stringent regulatory scenario

Restraints:
Stringent Regulatory Scenario Associated with Nutrigenomics Testing

Opportunities:
Rapid Advances in Molecular Biology and Genomics and Increasing Government Initiatives on Promoting Health in Developed Regions such as North America and Europe

Market Leaders and their expansionary development strategies
In April 2019, Nutrigenomix Inc., a global leader in genetic testing for personalized nutrition, announces the launch of an exclusive new line of genetic tests catering to those seeking plant-based personalized nutrition – designed to suit the dietary needs of both vegetarians and vegans. The new test adds to the broad selection of genetic tests offered by Nutrigenomix and provides actionable genetic information to help healthcare professionals and their clients determine the best dietary approach for optimal health, wellness, and performance for those following a plant-based lifestyle.
In June 2023, Xcode Life has launched a gene Nutrition test in India. The test covers nearly 50 aspects of nutrition including macro (carbs, protein, and fats) breakup according to genotype, vitamin and mineral deficiency risk, eating behaviors, weight management with nutrition, taste preferences, diet responses, and food sensitivities.


Key Target Audience
Nutrigenomics Testing Providers, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Obesity
  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
  • Women's Health
  • Neurological
  • Others
By Distribution Channel
  • Hospitals & Clinics
  • Online Platform

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Prevalence of Diabetes and Obesity
      • 3.2.2. High Adoption due to Changing Lifestyle and Consumption of Junk Food
    • 3.3. Market Challenges
      • 3.3.1. Stringent regulatory scenario
    • 3.4. Market Trends
      • 3.4.1. The Growing Trend of Personalized Diet among Athletes
      • 3.4.2. The Rising Importance of Nutritious Food among the Preventive Measures for Obesity and Related Ailments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nutrigenomics Testing, by Application, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Nutrigenomics Testing (Value)
      • 5.2.1. Global Nutrigenomics Testing by: Application (Value)
        • 5.2.1.1. Obesity
        • 5.2.1.2. Diabetes
        • 5.2.1.3. Cardiovascular Diseases
        • 5.2.1.4. Cancer Research
        • 5.2.1.5. Women's Health
        • 5.2.1.6. Neurological
        • 5.2.1.7. Others
      • 5.2.2. Global Nutrigenomics Testing by: Distribution Channel (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Online Platform
      • 5.2.3. Global Nutrigenomics Testing Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Nutrigenomics Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Koninklijke DSM N.V. (Royal DSM) (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BASF SE (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danone (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GeneSmart (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Unilever (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genova Diagnostics Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nutrigenomix, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Metagenics, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Nutrigenomics Testing Sale, by Application, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Nutrigenomics Testing (Value)
      • 7.2.1. Global Nutrigenomics Testing by: Application (Value)
        • 7.2.1.1. Obesity
        • 7.2.1.2. Diabetes
        • 7.2.1.3. Cardiovascular Diseases
        • 7.2.1.4. Cancer Research
        • 7.2.1.5. Women's Health
        • 7.2.1.6. Neurological
        • 7.2.1.7. Others
      • 7.2.2. Global Nutrigenomics Testing by: Distribution Channel (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Online Platform
      • 7.2.3. Global Nutrigenomics Testing Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nutrigenomics Testing: by Application(USD Million)
  • Table 2. Nutrigenomics Testing Obesity , by Region USD Million (2018-2023)
  • Table 3. Nutrigenomics Testing Diabetes , by Region USD Million (2018-2023)
  • Table 4. Nutrigenomics Testing Cardiovascular Diseases , by Region USD Million (2018-2023)
  • Table 5. Nutrigenomics Testing Cancer Research , by Region USD Million (2018-2023)
  • Table 6. Nutrigenomics Testing Women's Health , by Region USD Million (2018-2023)
  • Table 7. Nutrigenomics Testing Neurological , by Region USD Million (2018-2023)
  • Table 8. Nutrigenomics Testing Others , by Region USD Million (2018-2023)
  • Table 9. Nutrigenomics Testing: by Distribution Channel(USD Million)
  • Table 10. Nutrigenomics Testing Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 11. Nutrigenomics Testing Online Platform , by Region USD Million (2018-2023)
  • Table 12. South America Nutrigenomics Testing, by Country USD Million (2018-2023)
  • Table 13. South America Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 14. South America Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 15. Brazil Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 16. Brazil Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 17. Argentina Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 18. Argentina Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 19. Rest of South America Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 20. Rest of South America Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 21. Asia Pacific Nutrigenomics Testing, by Country USD Million (2018-2023)
  • Table 22. Asia Pacific Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 23. Asia Pacific Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 24. China Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 25. China Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 26. Japan Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 27. Japan Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 28. India Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 29. India Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 30. South Korea Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 31. South Korea Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 32. Taiwan Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 33. Taiwan Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 34. Australia Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 35. Australia Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 37. Rest of Asia-Pacific Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 38. Europe Nutrigenomics Testing, by Country USD Million (2018-2023)
  • Table 39. Europe Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 40. Europe Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 41. Germany Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 42. Germany Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 43. France Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 44. France Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 45. Italy Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 46. Italy Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 47. United Kingdom Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 48. United Kingdom Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 49. Netherlands Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 50. Netherlands Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 51. Rest of Europe Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 52. Rest of Europe Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 53. MEA Nutrigenomics Testing, by Country USD Million (2018-2023)
  • Table 54. MEA Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 55. MEA Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 56. Middle East Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 57. Middle East Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 58. Africa Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 59. Africa Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 60. North America Nutrigenomics Testing, by Country USD Million (2018-2023)
  • Table 61. North America Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 62. North America Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 63. United States Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 64. United States Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 65. Canada Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 66. Canada Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 67. Mexico Nutrigenomics Testing, by Application USD Million (2018-2023)
  • Table 68. Mexico Nutrigenomics Testing, by Distribution Channel USD Million (2018-2023)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Nutrigenomics Testing: by Application(USD Million)
  • Table 78. Nutrigenomics Testing Obesity , by Region USD Million (2025-2030)
  • Table 79. Nutrigenomics Testing Diabetes , by Region USD Million (2025-2030)
  • Table 80. Nutrigenomics Testing Cardiovascular Diseases , by Region USD Million (2025-2030)
  • Table 81. Nutrigenomics Testing Cancer Research , by Region USD Million (2025-2030)
  • Table 82. Nutrigenomics Testing Women's Health , by Region USD Million (2025-2030)
  • Table 83. Nutrigenomics Testing Neurological , by Region USD Million (2025-2030)
  • Table 84. Nutrigenomics Testing Others , by Region USD Million (2025-2030)
  • Table 85. Nutrigenomics Testing: by Distribution Channel(USD Million)
  • Table 86. Nutrigenomics Testing Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 87. Nutrigenomics Testing Online Platform , by Region USD Million (2025-2030)
  • Table 88. South America Nutrigenomics Testing, by Country USD Million (2025-2030)
  • Table 89. South America Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 90. South America Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 91. Brazil Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 92. Brazil Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 93. Argentina Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 94. Argentina Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 95. Rest of South America Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 96. Rest of South America Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 97. Asia Pacific Nutrigenomics Testing, by Country USD Million (2025-2030)
  • Table 98. Asia Pacific Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 99. Asia Pacific Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 100. China Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 101. China Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 102. Japan Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 103. Japan Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 104. India Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 105. India Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 106. South Korea Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 107. South Korea Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 108. Taiwan Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 109. Taiwan Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 110. Australia Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 111. Australia Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 112. Rest of Asia-Pacific Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 113. Rest of Asia-Pacific Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 114. Europe Nutrigenomics Testing, by Country USD Million (2025-2030)
  • Table 115. Europe Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 116. Europe Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 117. Germany Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 118. Germany Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 119. France Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 120. France Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 121. Italy Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 122. Italy Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 123. United Kingdom Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 124. United Kingdom Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 125. Netherlands Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 126. Netherlands Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 127. Rest of Europe Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 128. Rest of Europe Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 129. MEA Nutrigenomics Testing, by Country USD Million (2025-2030)
  • Table 130. MEA Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 131. MEA Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 132. Middle East Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 133. Middle East Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 134. Africa Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 135. Africa Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 136. North America Nutrigenomics Testing, by Country USD Million (2025-2030)
  • Table 137. North America Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 138. North America Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 139. United States Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 140. United States Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 141. Canada Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 142. Canada Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 143. Mexico Nutrigenomics Testing, by Application USD Million (2025-2030)
  • Table 144. Mexico Nutrigenomics Testing, by Distribution Channel USD Million (2025-2030)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nutrigenomics Testing: by Application USD Million (2018-2023)
  • Figure 5. Global Nutrigenomics Testing: by Distribution Channel USD Million (2018-2023)
  • Figure 6. South America Nutrigenomics Testing Share (%), by Country
  • Figure 7. Asia Pacific Nutrigenomics Testing Share (%), by Country
  • Figure 8. Europe Nutrigenomics Testing Share (%), by Country
  • Figure 9. MEA Nutrigenomics Testing Share (%), by Country
  • Figure 10. North America Nutrigenomics Testing Share (%), by Country
  • Figure 11. Global Nutrigenomics Testing share by Players 2023 (%)
  • Figure 12. Global Nutrigenomics Testing share by Players (Top 3) 2023(%)
  • Figure 13. Global Nutrigenomics Testing share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Koninklijke DSM N.V. (Royal DSM) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 16. Koninklijke DSM N.V. (Royal DSM) (Netherlands) Revenue: by Geography 2023
  • Figure 17. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 18. BASF SE (Germany) Revenue: by Geography 2023
  • Figure 19. Danone (France) Revenue, Net Income and Gross profit
  • Figure 20. Danone (France) Revenue: by Geography 2023
  • Figure 21. GeneSmart (United States) Revenue, Net Income and Gross profit
  • Figure 22. GeneSmart (United States) Revenue: by Geography 2023
  • Figure 23. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Unilever (United Kingdom) Revenue: by Geography 2023
  • Figure 25. Genova Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Genova Diagnostics Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Nutrigenomix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Nutrigenomix, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Metagenics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Metagenics, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Global Nutrigenomics Testing: by Application USD Million (2025-2030)
  • Figure 32. Global Nutrigenomics Testing: by Distribution Channel USD Million (2025-2030)
  • Figure 33. South America Nutrigenomics Testing Share (%), by Country
  • Figure 34. Asia Pacific Nutrigenomics Testing Share (%), by Country
  • Figure 35. Europe Nutrigenomics Testing Share (%), by Country
  • Figure 36. MEA Nutrigenomics Testing Share (%), by Country
  • Figure 37. North America Nutrigenomics Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Koninklijke DSM N.V. (Royal DSM) (Netherlands)
  • BASF SE (Germany)
  • Danone (France)
  • GeneSmart (United States)
  • Unilever (United Kingdom)
  • Genova Diagnostics Inc. (United States)
  • Nutrigenomix, Inc. (United States)
  • Metagenics, Inc. (United States)
Additional players considered in the study are as follows:
WellGen, Inc. (United States) , Cell Logic (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 203 Pages 91 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nutrigenomics Testing Market Quantitative research analysis
Global Nutrigenomics Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Koninklijke DSM N.V. (Royal DSM) (Netherlands), BASF SE (Germany), Danone (France), GeneSmart (United States), Unilever (United Kingdom), Genova Diagnostics Inc. (United States), Nutrigenomix, Inc. (United States) and Metagenics, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Growing Trend of Personalized Diet among Athletes " is seen as one of major influencing trends for Nutrigenomics Testing Market during projected period 2023-2030.
The Nutrigenomics Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Nutrigenomics Testing Market Report?

Have a Query? Click Here

Other Related Reports

Ayurveda Comprehensive Study by Application (Gastrointestinal Diseases, Cardiac Disorders, Respiratory Disorders, Psychological Disorders, Movement Disorders, Others), Treatment (Vamana, Virechana, N...
$ 3650
Single Cell Isolation Systems Comprehensive Study by Type (Flow Cytometry Systems, Microfluidic Systems, Laser Microdissection Systems, Others), Application (Drug Discovery, Life Science Research, Ot...
$ 3450
Elderly Care Facilities Comprehensive Study by Type (Pharmaceuticals, Housing and Assistive Devices), Application (Heart Diseases, Cancer, Kidney Diseases, Diabetes, Arthritis, Osteoporosis, Neurolog...
$ 3750
Hematology Therapies Comprehensive Study by Type (Instruments, Consumable), Application (Physiology, Pathology, Etiology, Diagnosis, Treatment, Prognosis), Blood Disorder Type (Hemophilia, Leukemia, ...
$ 3650
Healthcare and Hospital Room Furniture Comprehensive Study by Type (Chairs, Beds, Tables, Others), Application (Physicians Furniture, Patient Furniture, Staff Furniture), Department (Day Care, Emerge...
$ 3450
Coronavirus Diagnostics Comprehensive Study by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-C...
$ 3750